These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 36862209

  • 1. Calcifediol: a review of its pharmacological characteristics and clinical use in correcting vitamin D deficiency.
    Jodar E, Campusano C, de Jongh RT, Holick MF.
    Eur J Nutr; 2023 Jun; 62(4):1579-1597. PubMed ID: 36862209
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of a 10-day course of a high dose calciferol versus a single mega dose of ergocalciferol in correcting vitamin D deficiency.
    Melhem SJ, Aiedeh KM, Hadidi KA.
    Ann Saudi Med; 2015 Jun; 35(1):13-8. PubMed ID: 26142932
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: A randomized controlled trial in older adults.
    Vaes AMM, Tieland M, de Regt MF, Wittwer J, van Loon LJC, de Groot LCPGM.
    Clin Nutr; 2018 Jun; 37(3):808-814. PubMed ID: 28433267
    [Abstract] [Full Text] [Related]

  • 7. Efficacy, safety, and dose-response effects of calcifediol supplementation on 25-hydroxyvitamin D, parathyroid hormone, and 1,25-dihydroxyvitamin D levels in healthy adults: An open-label, interventional pilot study.
    Das L, Holick MF, Sachdeva N, Bhadada SK, Singhmar S, Thakur N, Dutta P, Marwaha RK.
    Indian J Pharmacol; 2023 Jun; 55(5):286-292. PubMed ID: 37929406
    [Abstract] [Full Text] [Related]

  • 8. Rapidly Increasing Serum 25(OH)D Boosts the Immune System, against Infections-Sepsis and COVID-19.
    Wimalawansa SJ.
    Nutrients; 2022 Jul 21; 14(14):. PubMed ID: 35889955
    [Abstract] [Full Text] [Related]

  • 9. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
    Wetmore JB, Kimber C, Mahnken JD, Stubbs JR.
    Br J Nutr; 2016 Dec 21; 116(12):2074-2081. PubMed ID: 28065190
    [Abstract] [Full Text] [Related]

  • 10. Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency.
    Sosa Henríquez M, Gómez de Tejada Romero MJ.
    Nutrients; 2020 May 31; 12(6):. PubMed ID: 32486496
    [Abstract] [Full Text] [Related]

  • 11. Fortified malted milk drinks containing low-dose ergocalciferol and cholecalciferol do not differ in their capacity to raise serum 25-hydroxyvitamin D concentrations in healthy men and women not exposed to UV-B.
    Fisk CM, Theobald HE, Sanders TA.
    J Nutr; 2012 Jul 31; 142(7):1286-90. PubMed ID: 22623396
    [Abstract] [Full Text] [Related]

  • 12. A pilot-randomized, double-blind crossover trial to evaluate the pharmacokinetics of orally administered 25-hydroxyvitamin D3 and vitamin D3 in healthy adults with differing BMI and in adults with intestinal malabsorption.
    Charoenngam N, Kalajian TA, Shirvani A, Yoon GH, Desai S, McCarthy A, Apovian CM, Holick MF.
    Am J Clin Nutr; 2021 Sep 01; 114(3):1189-1199. PubMed ID: 34008842
    [Abstract] [Full Text] [Related]

  • 13. 25(OH)D3-enriched or fortified foods are more efficient at tackling inadequate vitamin D status than vitamin D3.
    Guo J, Lovegrove JA, Givens DI.
    Proc Nutr Soc; 2018 Aug 01; 77(3):282-291. PubMed ID: 29173203
    [Abstract] [Full Text] [Related]

  • 14. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B, Pal J, Das S, Charaborty SK, SircarMedical NR, Kolkata, RGKar, NorthBengal, Siliguri.
    J Assoc Physicians India; 2023 Jan 01; 71(1):1. PubMed ID: 37116030
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Jan 01; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment With 25-Hydroxyvitamin D3 (Calcifediol) Is Associated With a Reduction in the Blood Neutrophil-to-Lymphocyte Ratio Marker of Disease Severity in Hospitalized Patients With COVID-19: A Pilot Multicenter, Randomized, Placebo-Controlled, Double-Blinded Clinical Trial.
    Maghbooli Z, Sahraian MA, Jamalimoghadamsiahkali S, Asadi A, Zarei A, Zendehdel A, Varzandi T, Mohammadnabi S, Alijani N, Karimi M, Shirvani A, Holick MF.
    Endocr Pract; 2021 Dec 01; 27(12):1242-1251. PubMed ID: 34653608
    [Abstract] [Full Text] [Related]

  • 19. Vitamin D supplementation in a post-pandemic era: A narrative review.
    Bopape PG, Wagenaar C, Poka M, Bronkhorst E.
    S Afr Fam Pract (2004); 2023 Oct 17; 65(1):e1-e6. PubMed ID: 37916701
    [Abstract] [Full Text] [Related]

  • 20. Calcifediol improves lipid profile in osteopenicatorvastatin-treated postmenopausal women.
    Catalano A, Morabito N, Basile G, Cucinotta D, Lasco A.
    Eur J Clin Invest; 2015 Feb 17; 45(2):144-9. PubMed ID: 25483366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.